Ms. Fisher is an "amazing strategist, who brings to bear her past experience, is very practical and doesn't lose sight of the details."Chambers USA 2014

Alice S. Fisher

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA
 
 

Alice Fisher is the Managing Partner of the Washington, D.C. office. She specializes in white collar criminal investigations, internal investigations and advises clients on a range of criminal matters, including:

  • International criminal matters relating to alleged bribery under the Foreign Corrupt Practices Act (FCPA) and other anti-corruption laws, economic and export sanctions, and other cross border investigations 
  • Criminal and civil fraud matters such as healthcare fraud, accounting and securities fraud, and procurement fraud 

  • Government enforcement inquiries and investigations in front of the US Department of Justice (DOJ), including the Drug Enforcement Administration, the Securities and Exchange Commission, the Consumer Fraud Protection Bureau and Congress

Ms. Fisher focuses her practice on corporate investigations and enforcement matters and provides strategic counsel to corporations on managing the legal risks of operating in a global economy.

From 2005-2008, Ms. Fisher served as Assistant Attorney General in charge of the Criminal Division of the US DOJ. As Assistant Attorney General, Ms. Fisher led more than 750 attorneys and staff responsible for federal criminal enforcement policy as well as handling criminal matters in federal courts across the country in all areas of federal criminal law enforcement. Under her leadership, the Criminal Division pursued a broad array of federal criminal investigations and prosecutions, with particular focus on corporate fraud matters, including securities fraud, procurement fraud, financial institution fraud, anti-money laundering, healthcare fraud, computer hacking and cyber security, national security, as well as US-domestic and international corruption.

Ms. Fisher also chaired the National Procurement Fraud Task Force, supervised the Medicare Fraud Strike Force, and served as a member of the President's Corporate Fraud Task Force. She handled various transnational and multi-national law enforcement operations and policies, including bilateral agreements and treaties involving information sharing and global criminal enforcement initiatives. Representing the DOJ in front of Congress, Ms. Fisher testified on criminal enforcement policies and served on the Federal Criminal Rules Committee.

As a litigation partner at Latham from 2003-2005 and prior to 2001, Ms. Fisher represented both individual and corporate clients in grand jury, agency and congressional inquiries involving allegations of securities and bank fraud, healthcare fraud, the FCPA, criminal antitrust matters, OFAC sanctions and procurement fraud. She has also represented clients in a number of complex civil and regulatory litigations. Ms. Fisher previously held other positions in government, including Deputy Special Counsel to a US Senate Special Committee.

Ms. Fisher has published articles and spoken on criminal law topics such as the criminalization of corporate conduct, the FCPA, healthcare and procurement fraud, the False Claims Act, the US criminal enforcement environment, public corruption and the honest services statute, financial crime in the financial services industry, securities fraud, identity theft, cybercrime and national security.

Ms. Fisher's recent experience includes representation of:

  • Global pharmaceutical companies in SEC and DOJ FCPA investigations resulting in settlement resolutions and declinations of prosecutions 
  • A foreign oil services company in US criminal investigation and compliance efforts resulting in a declination 
  • Several global manufacturing companies about maintaining FCPA compliance and obtaining two declinations of prosecution 
  • A retail pharmacy and distribution chain in a DEA investigation into distribution and sale of controlled substances 
  • A government contracting company in internal investigations relating to billing issues 
  • A global financial institution relating to international internal investigations 
  • A hospital chain in civil and criminal health care fraud investigations 
  • A private equity group in an accounting fraud investigation